LYCOS RETRIEVER Beta Retriever Home  |  What is Lycos Retriever?   
Brazil: Sao Paulo
built 617 days ago
APHIS and the Brazilian authorities are discussing lifting some of the fumigation requirements but no Directive has yet to be published by Brazil. Also, Brazil is considering building a fumigation facility in Sao Paulo. If built, Brazil would allow fumigation upon arrival.
Source:
SAO PAULO, Brazil (AP) - Brazilian aircraft manufacturer Embraer said Wednesday it is sticking to its plan of delivering 195-200 planes in 2008, after an executive suggested earlier that a lower figure was expected. AP
Brazil's climate has little seasonal variation since most of the country is located within the tropics. However, although 90% of the country is located within the tropical zone, year-long climate varies considerably from the mostly tropical North (the equator traverses the mouth of the Amazon) to temperate zones below the Tropic of Capricorn (23°27' S latitude), which crosses the country at the latitude of the city of São Paulo. Brazil has five climatic regions: equatorial, tropical, semiarid, highland tropical, and subtropical.
SAO PAULO, Brazil, Oct. 23 /PRNewswire-FirstCall/ -- TAM (Bovespa: TAMM4) has moved up the starting date of its new daily flight to Madrid, Spain to December 21. This service will depart from Guarulhos International Airport in Sao Paulo, arriving at Madrid-Barajas International Airport's Terminal 1. Passengers will travel on modern Airbus A330 aircraft with a choice of Executive or Economy class.
SAO PAULO, Brazil, Oct. 29 /PRNewswire-FirstCall/ -- TAM and the LAN alliance -- LAN Airlines, LAN Peru, LAN Argentina and LAN Ecuador -- will commence a code-share flight agreement on November 5, beginning with LAN Airlines (Chile). The flights will be available to sell beginning October 31. LAN Peru and LAN Argentina will follow in the month of November.
Source:
SAO PAULO, Brazil, July 9 /PRNewswire/ -- Abbott announced today that it achieved its goals in negotiating an agreement with the government of Brazil regarding Kaletra(R) (lopinavir/ritonavir), the leading protease inhibitor. The agreement accomplishes Abbott's objectives of helping Brazil expand patient access to Kaletra while preserving the company's intellectual property rights, which Abbott was not willing to negotiate.
Source:
SEARCH
MORE ABOUT